New study uses sleep monitoring and AI to detect Alzheimer's

https://www.news-medical.net/news/20260722/New-study-uses-sleep-monitoring-and-AI-to-detect-Alzheimers.aspx Researchers from Universidad Carlos III de Madrid (UC3M) and Hospital Universitario Severo Ochoa in Leganés, part of the public health network of the Comunidad de Madrid, have developed a methodology that uses artificial intelligence (AI) to analyze brain electrical activity during sleep and facilitate the early diagnosis of Alzheimer's. The study, recently published in the scientific journal GeroScience, demonstrates that analyzing nocturnal brain waves using machine learning techniques makes it possible to non-invasively identify early neural alterations and classify patients into three distinct biological subgroups.

Curcumin shows the best balance against cancer, study shows

https://www.news-medical.net/news/20260722/Curcumin-shows-the-best-balance-against-cancer-study-shows.aspx Curcumin, berberine, and other plant-derived compounds have long attracted scientific interest because of their anti-inflammatory and anticancer properties. A new study by researchers from Wroclaw Medical University and the University of Wroclaw, however, shows that not all natural compounds act in the same way, and strong anticancer activity does not always go hand in hand with a good safety profile.

Study reveals how p53 mutations cause tumors to resist cancer immunotherapy

https://www.news-medical.net/news/20260722/Study-reveals-how-p53-mutations-cause-tumors-to-resist-cancer-immunotherapy.aspx Immune checkpoint blockade (ICB) therapy has transformed cancer treatment, but many tumors remain resistant. A new study from researchers at the Hackensack Meridian Center for Discovery and Innovation (CDI) identifies a previously unrecognized mechanism by which mutations in the p53 gene can limit the effectiveness of immunotherapy-while also revealing a potential strategy to overcome this resistance.

Singing therapy provides effective relief for supragastric belching patients

https://www.news-medical.net/news/20260722/Singing-therapy-provides-effective-relief-for-supragastric-belching-patients.aspx A new randomized clinical trial suggests that singing therapy may provide a more effective and engaging treatment option than standard breathing exercises for people with supragastric belching, a chronic gastrointestinal disorder that can significantly affect quality of life. The study, which will be published in the American Gastroenterological Association's journal Clinical Gastroenterology and Hepatology, is the first randomized controlled trial to evaluate singing therapy for supragastric belching. This condition causes rapid, excessive belching - sometimes hundreds to thousands of times a day - as air repeatedly enters and exits the esophagus rather than the stomach. Researchers found that structured singing therapy provided significantly greater short-term symptom relief compared with diaphragmatic breathing therapy, the current first-line behavioral treatment for the condition.

Moderate coffee intake may support heart health, AHA says

https://www.news-medical.net/news/20260721/Moderate-coffee-intake-may-support-heart-health-AHA-says.aspx A recent scientific statement published by the American Heart Association in the journal Circulation suggests that habitual coffee consumption is associated with lower risks of several cardiovascular outcomes, although this does not establish a protective effect of caffeine itself.

Indicators of Discriminatory Motive in Crimes of Sexual Violence Against Women in Georgia European Scientific Journal ESJ

https://www.academia.edu/170574801/Indicators_of_Discriminatory_Motive_in_Crimes_of_Sexual_Violence_Against_Women_in_Georgia This article examines whether sexual violence should be understood as a crime motivated by gender-based discrimination and identifies contextual indicators for establishing a discriminatory motive in criminal proceedings. Drawing on international and regional human rights law, feminist legal theory and an analysis of Georgian judicial practice, it argues that sexual violence is not merely an act of individual aggression but a manifestation of systemic gender inequality and patriarchal power. The article demonstrates that discriminatory motive is often structurally embedded rather than expressed through overt hostility and therefore should be assessed through contextual indicators, similar to those used in hate crime analysis. It further argues that the existence of multiple motives does not preclude the recognition of a discriminatory motive. Finally, the article recommends strengthening the application of contextual analysis in Georgian criminal justice practice to improve the recognition of discriminatory motive in sexual violence cases and to advance survivor-centred and transformative justice.

Building Care Plans With Radiopharmaceuticals for Patients With mCRPC Authors: Neal D. Shore, MD, FACS; Alicia Morgans, MD, MPH, FASCO; Chad Tang, MD

https://www.medscape.org/viewarticle/building-care-plans-radiopharmaceuticals-patients-mcrpc-2026a10007zy?page=1&src=mkmcmr_driv_stan_mscpedu_260722-OUS-HONC-building-care-plans-radiopharmaceuticals-patients-mcrpc-2026a10007zy-cta&uac=148436CN

Think You Know IDH-Mutant Glioma? Test Your Clinical Expertise on the Latest Advances Authors: Patrick Y. Wen, MD

https://www.medscape.org/viewarticle/think-you-know-idh-mutant-glioma-test-your-clinical-2025a1000bve?page=1&uac=148436CN&src=mkm_driv_cust_mscpedu_260722-11966847

Highlights from the Annual Neurosurgical Conference: New Standards in Diffuse Lower-Grade Glioma Authors: Mitchel S. Berger, MD; Macarena de la Fuente, MD; Michael Lim, MD

https://www.medscape.org/viewarticle/1002598?uac=148436CN&src=mkm_driv_cust_mscpedu_260722-1002598

Next-Generation Imaging: Expert Insights for Clinical Excellence

https://www.medscape.org/advances/advancing-clinical-excellence-precision-imaging-2025a1000ayx?src=mkmcmr_driv_32025_mscpedu_451838.01_ace_launch&uac=148436CN Next Generation Imaging Radiology is a cornerstone of modern healthcare, significantly improving patient care through accurate diagnostics, effective treatment planning, and ongoing patient monitoring. As innovations in imaging reshape patient care, it is essential for radiologists, radiologic technologists, specialists, and referring clinicians to stay informed about the latest best practices in radiology.

Assessing Conditioning Regimens for HSCT: Optimizing Patient Outcomes Authors: Mohamad Mohty, MD, PhD; Daniele Avenoso, MD, PhD; Simona Sica, MD, PhD; Sergio Giralt, MD, FACP, FASTCT

https://www.medscape.org/viewarticle/assessing-conditioning-regimens-hsct-optimizing-patient-2026a1000ntg?page=1

The Intensity Equation: Aligning Multiple Myeloma Combination Strategies With Current Evidence Authors: Luciano Costa, MD, PhD; Sikander Ailawadhi, MD; Nisha S. Joseph, MD

https://www.medscape.org/viewarticle/intensity-equation-aligning-multiple-myeloma-combination-2026a1000ntz?page=1

Elevating CLL Care: Integrating Evidence, Guidelines, and the Patient Perspective Authors: Jennifer A. Woyach, MD; Stephan Stilgenbauer, MD; Lorna Warwick

https://www.medscape.org/viewarticle/elevating-cll-care-integrating-evidence-guidelines-and-2026a1000nxr?page=1

Intentional Outdoor Tanning Common Among US Adults Edited by Deepa Varma July 22, 2026

https://www.medscape.com/viewarticle/intentional-outdoor-tanning-common-among-us-adults-2026a1000otn?src= More than 30% of US adults in a national survey intentionally tanned outdoors, increasing their risk for sunburn, with findings that have implications for skin cancer prevention measures.

Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup Edited by Gargi Mukherjee

https://www.medscape.com/viewarticle/quizartinib-benefit-aml-limited-flt3-mutated-subgroup-2026a1000oqq?src= Adding quizartinib after intensive chemotherapy was associated with improved 5-year overall survival among older patients with FLT3-mutated AML in subgroup analyses, but not in the overall trial population, where quizartinib was associated with increased nonrelapse mortality. No additional benefit was seen with extended quizartinib maintenance therapy in the overall population or the wild-type FLT3 AML group.

5 Ways to Improve Care for Cancer Survivors Michael van den Heuvel July 22, 2026

https://www.medscape.com/viewarticle/5-ways-improve-care-cancer-survivors-2026a1000ord?src= Advances in oncology have significantly improved the prognosis for many types of cancer in recent years. Modern immunotherapies, targeted drugs, optimized surgical procedures, and more precise radiation therapies now enable many patients to live with cancer for years or even indefinitely.

How Can Cancer Therapy Be Adjusted in Patients Having Derm Surgery? Ted Bosworth July 22, 2026 J Am Acad Dermatol. 2026; doi:10.1016/j.jaad.2026.06.126

https://www.medscape.com/viewarticle/how-can-cancer-therapy-be-adjusted-patients-having-derm-2026a1000ots?src= Addressing what they consider an unmet need, a multidisciplinary group has issued new recommendations for treating patients receiving systemic therapies for cancer who are undergoing surgical resection of a concomitant dermatologic malignancy. “Prior to this review, there was not a comprehensive framework [for adjusting systemic cancer therapy] tailored to dermatologic surgery,” explained the lead author of the guidance, Megan H. Trager, MD, MS.

Life After Childhood Cancer Needs Better Follow-Up Nekane Lauzirika

https://www.medscape.com/viewarticle/life-after-childhood-cancer-needs-better-follow-2026a1000oqs?src= With advances in early diagnosis, surgery, chemotherapy, radiation therapy, and targeted treatments, the survival rate for childhood cancer now exceeds 80%. But experts say the real challenge begins after treatment ends: ensuring these survivors are monitored for and managed through the long-term effects that can emerge months or even years later.

Lecanemab for AD Shows Sustained Benefit in Real-World Study

https://www.medscape.com/viewarticle/lecanemab-ad-shows-sustained-benefit-real-world-study-2026a1000ofl?ecd=WNL_trdalrt_pos1_ous_260722_etid8527635&uac=148436CN&impID=8527635 LONDON — More than 80% of patients with early Alzheimer’s disease (AD) treated with lecanemab (Leqembi, Eisai/Biogen) in routine practice remained clinically stable or improved over an average of 17 months of treatment, an interim analysis of the real-world LEADER study showed.

The invisible struggle: charting the complex reality of CIDP 8 July 2026

https://rarerevolutionmagazine.com/the-invisible-struggle-charting-the-complex-reality-of-cidp/ Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare, fluctuating autoimmune condition that attacks the peripheral nerves, causing progressive muscle weakness, sensory loss and an often ‘invisible’ struggle. While clinical metrics track measurable symptoms like muscle strength, the real measure of life with CIDP lies in the daily unpredictability and emotional toll of a condition that few can understand. Global patient leaders Gabi Faust, Jean-Philippe Plançon, Marian Ciopec and Nancy Di Salvo, chart a course through the diagnostic odyssey and beyond Written by Nicola Miller, RARE Revolution Community insights from Gabi Faust, chair, GBS CIDP Self-Help Organisation Jean-Philippe Plançon, president, EPODIN (European Patients Organization for Dysimmune and Inflammatory Neuropathies) Marian Ciopec, executive manager, EPODIN Nancy Di Salvo, international affairs director, GBS-CIDP Foundation International

THC drinks are sold beside sodas, iced tea, and even chocolate milk, often in violation of state laws Health risks of the cannabis ingredient for kids and teens alarm doctors By Sarah ToddJuly 21, 2026

THC drinks are sold beside sodas, iced tea, and even chocolate milk, often in violation of state laws Health risks of the cannabis ingredient for kids and teens alarm doctors By Sarah ToddJuly 21, 2026 https://www.statnews.com/2026/07/21/thc-drinks-risk-accidental-ingestion-issue-labels-regulations/ Receso Invernal del grupo de blog´s de "salud equitativa"... los días 26, 27, 28, 29, y 30 de julio de 2026, los blog´s no se actualizarán... pedimos disculpas por ello, pero esperamos sepan entender que merecemos un descanso... regresaremos el 31 de julio si Dios lo permite... muchas gracias a todos los lectores y seguidores (que cada vez son más)... hasta entonces... El editor... Grupo de blog´s de “salud equitativa”, cuyo titular es Víctor Norberto Cerasale Morteo, en Salta, Argentina… https://wwweldispreciau.blogspot.com/ https://eldispensador.blogspot.com/ https://saludequitativa.blogspot.com/ https://herenciageneticayenfermedad.blogspot.com/ https://elbiruniblogspotcom.blogspot.com/ Winter Break for the "Equitable Health" Blog Group... the blogs will not be updated on July 26, 27, 28, 29, and 30, 2026... We apologize for this, but we hope you understand that we deserve a break... We will return on July 31, God willing... Many thanks to all our readers and followers (whose numbers are constantly growing)... Until then... The Editor... "Equitable Health" Blog Group, owned by Víctor Norberto Cerasale Morteo, in Salta, Argentina... https://wwweldispreciau.blogspot.com/ https://eldispensador.blogspot.com/ https://saludequitativa.blogspot.com/ https://herenciageneticayenfermedad.blogspot.com/ https://elbiruniblogspotcom.blogspot.com/ Pause hivernale pour le groupe de blogs « Equitable Health »… Les articles ne seront pas mis à jour les 26, 27, 28, 29 et 30 juillet 2026… Nous vous prions de nous excuser pour ce désagrément, mais nous espérons que vous comprendrez que nous méritons bien une pause… Nous serons de retour le 31 juillet, si Dieu le veut… Un grand merci à tous nos lecteurs et abonnés (dont le nombre ne cesse de croître)… À bientôt… La rédaction… Le groupe de blogs « Equitable Health », propriété de Víctor Norberto Cerasale Morteo, à Salta, en Argentine… https://wwweldispreciau.blogspot.com/ https://eldispensador.blogspot.com/ https://saludequitativa.blogspot.com/ https://herenciageneticayenfermedad.blogspot.com/ https://elbiruniblogspotcom.blogspot.com/ Winterpause für die Bloggruppe „Gerechte Gesundheit“ … Die Blogs werden am 26., 27., 28., 29. und 30. Juli 2026 nicht aktualisiert. Wir bitten um Entschuldigung und hoffen auf Ihr Verständnis, dass wir uns eine Auszeit verdient haben. Wir sind am 31. Juli wieder für Sie da, so Gott will. Vielen Dank an alle unsere Leser und Follower (deren Zahl stetig wächst). Bis dahin … Die Redaktion der Bloggruppe „Gerechte Gesundheit“, Inhaber: Víctor Norberto Cerasale Morteo, Salta, Argentinien. https://wwweldispreciau.blogspot.com/ https://eldispensador.blogspot.com/ https://saludequitativa.blogspot.com/ https://herenciageneticayenfermedad.blogspot.com/ https://elbiruniblogspotcom.blogspot.com/ Зимний перерыв для блог-группы "Equitable Health"... блоги не будут обновляться 26, 27, 28, 29 и 30 июля 2026 года... Приносим свои извинения, но надеемся на ваше понимание, что мы заслужили перерыв... Мы вернемся 31 июля, если Бог даст... Большое спасибо всем нашим читателям и подписчикам (число которых постоянно растет)... До тех пор... Редактор... Блог-группа "Equitable Health", принадлежащая Виктору Норберто Серасале Мортео, Сальта, Аргентина... https://wwweldispreciau.blogspot.com/ https://eldispensador.blogspot.com/ https://saludequitativa.blogspot.com/ https://herenciageneticayenfermedad.blogspot.com/ https://elbiruniblogspotcom.blogspot.com/ "इक्विटेबल हेल्थ" ब्लॉग ग्रुप के लिए विंटर ब्रेक... ब्लॉग 26, 27, 28, 29, और 30 जुलाई, 2026 को अपडेट नहीं किए जाएंगे... हम इसके लिए माफ़ी चाहते हैं, लेकिन हमें उम्मीद है कि आप समझेंगे कि हम एक ब्रेक के हकदार हैं... हम 31 जुलाई को वापस आएंगे, भगवान चाहेंगे... हमारे सभी रीडर्स और फॉलोअर्स (जिनकी संख्या लगातार बढ़ रही है) का बहुत-बहुत धन्यवाद... तब तक... एडिटर... "इक्विटेबल हेल्थ" ब्लॉग ग्रुप, जिसके मालिक विक्टर नॉरबर्टो सेरासले मोर्टेओ हैं, साल्टा, अर्जेंटीना में है... https://wwweldispreciau.blogspot.com/ https://eldispensador.blogspot.com/ https://saludequitativa.blogspot.com/ https://herenciageneticayenfermedad.blogspot.com/ https://elbiruniblogspotcom.blogspot.com/ Recesso de Inverno para o Grupo de Blogs "Saúde Equitativa"... os blogs não serão actualizados nos dias 26, 27, 28, 29 e 30 de Julho de 2026... Pedimos desculpa por isso, mas esperamos que compreendam que merecemos uma pausa... Regressaremos no dia 31 de Julho, se Deus quiser... Muito obrigado a todos os nossos leitores e seguidores (cujo número está em constante crescimento)... Até lá... A Equipa Editorial... Grupo de Blogs "Saúde Equitativa", propriedade de Víctor Norberto Cerasale Morteo, em Salta, Argentina... https://wwweldispreciau.blogspot.com/ https://eldispensador.blogspot.com/ https://saludequitativa.blogspot.com/ https://herenciageneticayenfermedad.blogspot.com/ https://elbiruniblogspotcom.blogspot.com/ Pausa invernale per il gruppo di blog "Equitable Health"... i blog non verranno aggiornati il 26, 27, 28, 29 e 30 luglio 2026... Ci scusiamo per questo, ma speriamo che comprendiate che ci meritiamo una pausa... Torneremo il 31 luglio, a Dio piacendo... Un sentito ringraziamento a tutti i nostri lettori e follower (il cui numero è in costante crescita)... A presto... Il Direttore... Gruppo di blog "Equitable Health", di proprietà di Víctor Norberto Cerasale Morteo, a Salta, Argentina... https://wwweldispreciau.blogspot.com/ https://eldispensador.blogspot.com/ https://saludequitativa.blogspot.com/ https://herenciageneticayenfermedad.blogspot.com/ https://elbiruniblogspotcom.blogspot.com/ "ஈக்விடபிள் ஹெல்த்" வலைப்பதிவுக் குழுவிற்கு குளிர்கால இடைவேளை... ஜூலை 26, 27, 28, 29, மற்றும் 30, 2026 ஆகிய தேதிகளில் வலைப்பதிவுகள் புதுப்பிக்கப்படாது... இதற்காக வருந்துகிறோம், ஆனால் எங்களுக்கு ஒரு இடைவேளை தேவை என்பதை நீங்கள் புரிந்துகொள்வீர்கள் என்று நம்புகிறோம்... எல்லாம் வல்ல இறைவனின் அருளால், ஜூலை 31 அன்று நாங்கள் திரும்புவோம்... எங்கள் வாசகர்கள் மற்றும் பின்தொடர்பவர்கள் அனைவருக்கும் மிக்க நன்றி (அவர்களின் எண்ணிக்கை தொடர்ந்து அதிகரித்து வருகிறது)... அதுவரை... ஆசிரியர்... "ஈக்விடபிள் ஹெல்த்" வலைப்பதிவுக் குழு, விக்டர் நோர்பெர்டோ செராசேல் மோர்டியோவுக்குச் சொந்தமானது, சால்டா, அர்ஜென்டினா... https://wwweldispreciau.blogspot.com/ https://eldispensador.blogspot.com/ https://saludequitativa.blogspot.com/ https://herenciageneticayenfermedad.blogspot.com/ https://elbiruniblogspotcom.blogspot.com/ “公平健康”博客组冬季休刊……博客将于2026年7月26日、27日、28日、29日和30日暂停更新……对此我们深表歉意，但希望您能理解我们需要休息……我们将于7月31日恢复更新，如果一切顺利……非常感谢所有读者和关注者（人数还在不断增长）……此致……编辑……“公平健康”博客组，由阿根廷萨尔塔省的维克托·诺贝托·塞拉萨莱·莫特奥所有…… https://wwweldispreciau.blogspot.com/ https://eldispensador.blogspot.com/ https://saludequitativa.blogspot.com/ https://herenciageneticayenfermedad.blogspot.com/ https://elbiruniblogspotcom.blogspot.com/

Psychiatric patients show reduced flexibility in their brain network dynamics

https://www.news-medical.net/news/20260721/Psychiatric-patients-show-reduced-flexibility-in-their-brain-network-dynamics.aspx Individuals with psychiatric conditions show reduced flexibility in their brain network dynamics, according to a new Rutgers study. The human brain is organized into networks that can adaptively shift and reorganize to meet ever-changing cognitive and emotional demands. This flexible reconfiguration of brain networks over time supports our ability to regulate our thoughts and behavior. Disruptions in the brain's dynamic processes are thought to play an important role in psychiatric illness. However, it remains unclear how differences in brain network dynamics relate to the wide range of symptoms seen across mental health conditions.

Medically tailored grocery deliveries improve blood sugar control among diabetes patients

https://www.news-medical.net/news/20260721/Medically-tailored-grocery-deliveries-improve-blood-sugar-control-among-diabetes-patients.aspx A study from researchers at top US health insurance and medical services provider Kaiser Permanente, the Food is Medicine Institute at the Gerald J. and Dorothy R. Friedman School of Nutrition Science and Policy at Tufts University and The George Institute for Global Health found medically tailored grocery deliveries improved blood sugar control among adults living with type 2 diabetes who have public health insurance, when compared with usual care. The findings show that integrating Food is Medicine approaches into clinical care can improve both diabetes outcomes and food and nutrition security for patients. The study is published in the journal Circulation.

Scientists link genetic spelling mistakes to sudden cardiac death

https://www.news-medical.net/news/20260721/Scientists-link-genetic-spelling-mistakes-to-sudden-cardiac-death.aspx Scientists have found that the 'sudden' cardiac death condition related to high profile deaths or major medical episodes of sports stars including Fabrice Muamba, Christian Erikson and Mark-Vivian Foe has numerous linked gene variations, or "spelling mistakes", which highlights a potentially treatable vulnerability.

How Immune Dysregulation Contributes to Psychiatric Disorders

https://www.news-medical.net/health/How-Immune-Dysregulation-Contributes-to-Psychiatric-Disorders.aspx From inflammatory signals to genetic risk, emerging research is revealing how the immune system may shape psychiatric illness and why future treatments may need to target the biology of specific patient subgroups. Growing evidence suggests that disruptions in immune function may play an important role in the development and progression of psychiatric disorders. However, immune mechanisms probably contribute more strongly in some patients than others, and observed abnormalities may represent causal factors, consequences of illness or treatment, or shared confounding influences.2,3

Navigating Advances in TRK Fusion-Positive Cancers: A Collaborative Journey From Testing to Therapy Authors: David S. Hong, MD; Theodore W. Laetsch, MD; Jonathan C. Trent, MD, PhD

https://www.medscape.org/viewarticle/navigating-advances-trk-fusion-positive-cancers-2025a1000z5i?page=1&src=mkmcmr_driv_stan_mscpedu_260719-OUS-HONC-navigating-advances-trk-fusion-positive-cancers-2025a1000z5i-cta&uac=148436CN

Human airway model reveals why babies develop severe RSV

Human airway model reveals why babies develop severe RSV Researchers find that infant airway tissue actively shapes the immune response to RSV, suggesting future therapies should target both the virus and inflammation. Written byBree Foster, PhD https://www.drugdiscoverynews.com/human-airway-model-reveals-why-babies-develop-severe-rsv-17333?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz-_DykP2Osc0SJfgtPqArDXrNBMrfTCF0K1MeR9BhAiWvrgs6coqYA7kf1WMNLpadxAIcTdiWiizNTwMYSWcYA2aItue7w&_hsmi=429281211&utm_content=429281211&utm_source=hs_email Respiratory syncytial virus (RSV) is the leading cause of severe lower respiratory tract infections in infants, accounting for an estimated 3.6 million hospitalizations worldwide and more than 100,000 deaths in children under five each year. Although preventive antibodies have improved protection for vulnerable infants, treatment options once babies become seriously ill remain largely limited to supportive care.

Managing Myeloproliferative Neoplasms: Practice Your Skills in These Virtual Patient Simulations Authors: Claire N. Harrison, DM, FRCP, FRCPath; Haifa Kathrin Al-Ali, MD

https://www.medscape.org/viewarticle/managing-myeloproliferative-neoplasms-practice-your-skills-2026a1000f5o?page=1

Pott’s Puffy Tumor in Teen Leads to Bilateral Blindness Julia Senn

https://www.medscape.com/viewarticle/potts-puffy-tumor-teen-leads-bilateral-blindness-2026a1000og3 Pott’s puffy tumor (PPT) is a rare but life-threatening complication of sinusitis, characterized by frontal bone osteomyelitis with a subperiosteal abscess. Because intracranial and orbital extension can occur rapidly, early recognition and prompt multidisciplinary management are essential to reduce the risk for permanent neurologic and visual sequelae.

Delays Harmless for Most Macular Degeneration Patients Richard Mark Kirkner

https://www.medscape.com/viewarticle/delays-harmless-most-macular-degeneration-patients-2026a1000on1 Short prior authorization delays for drug therapy did not cause vision loss in most patients newly diagnosed with age-related macular degeneration (AMD). However, a small number of people — especially those with subretinal hemorrhage — experienced loss of visual acuity while waiting and failed to recover after 6 months.

Noncardia Gastric Cancer Risk Higher in Hispanic and Asian Populations Edited by Shrabasti Bhattacharya July 21, 2026 ++ ++ ++ +

Noncardia Gastric Cancer Risk Higher in Hispanic and Asian Populations Edited by Shrabasti Bhattacharya https://www.medscape.com/viewarticle/noncardia-gastric-cancer-risk-higher-hispanic-and-asian-2026a1000on5?src= In the US, the incidence of noncardia gastric cancer was more than three times higher among Hispanic and non-Hispanic Asian or Pacific Islander populations than among non-Hispanic White populations. Incidence rates seen in non-Hispanic White adults aged 60-69 years occurred up to two decades earlier in several Asian groups. Blood Test Flags Gynaecologic Cancer Risk in NHS Trial Dr Sheena Meredith https://www.medscape.com/viewarticle/blood-test-flags-gynaecological-cancer-risk-nhs-trial-2026a1000omh?src= A blood test has correctly flagged more than 99% of gynaecologic cancers as elevated or high risk in the largest real-world evaluation of an AI-enabled cancer triage tool carried out in the NHS, according to a study published in Mayo Clinic Proceedings Digital Health. Focal Therapy Shows Favorable Long-Term Outcomes in Prostate Cancer Edited by Victoria Stern https://www.medscape.com/viewarticle/focal-therapy-shows-favorable-long-term-outcomes-prostate-2026a1000oma?src= July 21, 2026 Eur Urol. 2026; doi:10.1016/j.eururo.2026.05.007 A retrospective study provides the largest contemporary analysis of long-term outcomes of focal therapy in patients with nonmetastatic prostate cancer, reporting low 10-year cancer-specific mortality (0.13%) and metastasis rates (3.3%) among the nearly 3500 patients who received focal therapy using high-intensity focused ultrasound (HIFU) or cryotherapy. Use of Adjuvant Radiation Therapy Remains Stagnant for Localized Merkel Cell Edited by Gargi Mukherjee https://www.medscape.com/viewarticle/use-adjuvant-radiation-therapy-remains-stagnant-localized-2026a1000oig?src= July 20, 2026 J Am Acad Dermatol. 2026; Adjuvant radiation therapy (RT) use increased modestly among surgically treated patients with Merkel cell carcinoma (MCC) between 2000 and 2020, but rates did not increase for localized disease. doi:10.1016/j.jaad.2026.07.022 Adjuvant Chemo Tied to Longer Survival After Pelvic Exenteration Edited by Victoria Stern https://www.medscape.com/viewarticle/adjuvant-chemo-tied-longer-survival-after-pelvic-2026a1000oez?src= July 20, 2026 JAMA Netw Open. 2026;9(6):e2620335. doi:10.1001/jamanetworkopen.2026.20335 Adjuvant chemotherapy was associated with substantially longer median overall survival (28 vs 10 months) in patients undergoing pelvic exenteration for gynecologic cancers with pelvic lymph node metastasis. Chemotherapy was also associated with significantly longer median disease-free survival (DFS; 20 vs 7 months) and cancer-specific survival (28 vs 13 months). CSF Biomarker Panel May Improve Diagnosis of CNS Lymphoma Edited by Gargi Mukherjee https://www.medscape.com/viewarticle/csf-biomarker-panel-may-improve-diagnosis-cns-lymphoma-2026a1000ok8?src= July 21, 2026 Lancet Haematol. 2026;13(6):e376-e385. doi:10.1016/S2352-3026(26)00098-0 A cerebrospinal fluid (CSF) biomarker panel, combining MYD88 mutation testing with interleukin 10 (IL-10) and C-X-C motif chemokine ligand 13 (CXCL13) measurements, showed high specificity for CNS lymphoma and correctly identified more than half of the CNS lymphoma cases. With further validation, this panel could help reduce reliance on invasive brain biopsy in selected patients, the authors suggested. Glucose and A1c Mediate the Risk for Obesity-Related Pancreatic Cancer Edited by Gargi Mukherjee https://www.medscape.com/viewarticle/glucose-and-a1c-mediate-risk-obesity-related-pancreatic-2026a1000o64?src= Obesity increased the risk for pancreatic cancer by 20% per SD increase in BMI, with glucose and A1c mediating approximately 16% and 20% of this association, respectively.

Patients With Early-Onset Cancer Unaware of Infertility Risk Edited by Gargi Mukherjee July 20, 2026

https://www.medscape.com/viewarticle/patients-early-onset-cancer-unaware-infertility-risk-2026a1000oh5 In a study of adults diagnosed with cancer before age 50, 30% said they were never informed that treatments could affect their fertility. Awareness was especially low among patients from racial and ethnic minority groups and those with prior pregnancies.

Can Hypothalamic Damage Trigger Obesity? Ute Eppinger

https://www.medscape.com/viewarticle/can-hypothalamic-damage-trigger-obesity-2026a1000oal?ecd=WNL_trdalrt_pos1_ous_260721_etid8524394&uac=148436CN&impID=8524394 Disruption of the brain’s hunger and satiety control mechanisms can lead to rapid weight gain that is difficult to treat with conventional dietary interventions because patients do not experience an adequate sense of fullness. Speaking at a joint press conference hosted by the German Diabetes Society and the German Society of Endocrinology, Ulrich Dischinger, MD, senior physician in the Department of Endocrinology and Diabetology at the University Hospital of Würzburg in Würzburg, Germany, emphasized that hypothalamic obesity is a distinct clinical condition that remains underrecognized.

The end for avacopan The Lancet Rheumatology +... +

The end for avacopan The Lancet Rheumatology https://www.thelancet.com/journals/lanrhe/issue/vol8no8/PIIS2665-9913(26)X2007-0 Prevalence and determinants of sacroiliac joint bone marrow oedema in the general population in Germany: a population-based cross-sectional study Keno Bressem, MDa,b,n,* Send email to keno.bressem@tum.de ∙ Murat Torgutalp, MDc,d,h,* ∙ Prof Torsten Diekhoff, MDi ∙ Nikolaos Kougkas, MDj ∙ Lina Xu, MDe ∙ Janis L Vahldiek, MDe ∙ et al. https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(26)00071-8/fulltext?dgcid=raven_jbs_etoc_feature_lanrhe

Viewpoint: Is bagged salad a dangerous science experiment? Challenging an online misinformation campaign Yahoo News | July 20, 2026

https://geneticliteracyproject.org/2026/07/20/viewpoint-is-bagged-salad-a-dangerous-science-experiment-challenging-an-online-misinformation-campaign/

Rapamycin: Here’s the skinny on the anti-aging pill that increases the lifespan—of mice by 10% Joseph James | Medical Daily | July 21, 2026

https://geneticliteracyproject.org/2026/07/21/rapamycin-heres-the-skinny-on-the-anti-aging-pill-that-increases-the-lifespan-of-mice-by-10/

Are we edging closer to precisely, and safely, editing human embryos? Max Barnhart | Chemical and Engineering News | July 21, 2026

https://geneticliteracyproject.org/2026/07/21/are-we-edging-closer-to-precisely-and-safely-editing-human-embryos/

40 million Americans take glucosamine. If you have memory loss, it could accelerate cognitive decline. Ramon Sun | July 20, 2026

https://geneticliteracyproject.org/2026/07/20/40-million-americans-take-glucosamine-if-you-have-memory-loss-it-could-accelerate-cognitive-decline/

Dr. TikTok and male fertility: Viral claims tout GLP-1 drugs as fertility boosters. What does the science say? Chuck Dinerstein | July 21, 2026

https://geneticliteracyproject.org/2026/07/21/dr-tiktok-and-male-fertility-viral-claims-tout-glp-1-drugs-as-fertility-boosters-what-does-the-science-say/ The “TikTok Medical Group” has stirred the viral waters around biohacking male infertility. GLP-1 receptor agonists are proving to be potentially powerful tools for quietly resetting the delicate hormonal axis that governs male reproductive health. It is time to separate TikTok science fiction from physiological reality.

More and more babies are developing uncontrollable bleeding—linked directly to vaccine deniers’ rejection of vitamin K shots Sarah Boden | University of Minnesota | July 21, 2026

https://geneticliteracyproject.org/2026/07/21/more-and-more-babies-are-developing-uncontrollable-bleeding-linked-directly-to-vaccine-deniers-rejection-of-vitamin-k-shots/

Clinical Perspectives on the Use of PI3K/AKT Pathway Inhibitors in the Management of HR+/HER2− Metastatic Breast Cancer Authors: Peter Schmid, MD, PhD, FRCP; Kevin Kalinsky, MD, MS, FASCO; Frédérique Penault-Llorca, MD, PhD

https://www.medscape.org/viewarticle/clinical-perspectives-use-pi3k-akt-pathway-inhibitors-2026a100087h?page=1&src=mkmcmr_driv_stan_mscpedu_260719-OUS-HONC-clinical-perspectives-use-pi3k-akt-pathway-inhibitors-2026a100087h-cta&uac=148436CN Receso Invernal del grupo de blog´s de "salud equitativa"... los días 26, 27, 28, 29, y 30 de julio de 2026, los blog´s no se actualizarán... pedimos disculpas por ello, pero esperamos sepan entender que merecemos un descanso... regresaremos el 31 de julio si Dios lo permite... muchas gracias a todos los lectores y seguidores (que cada vez son más)... hasta entonces... El editor... Grupo de blog´s de “salud equitativa”, cuyo titular es Víctor Norberto Cerasale Morteo, en Salta, Argentina… https://wwweldispreciau.blogspot.com/ https://eldispensador.blogspot.com/ https://saludequitativa.blogspot.com/ https://herenciageneticayenfermedad.blogspot.com/ https://elbiruniblogspotcom.blogspot.com/ Winter Break for the "Equitable Health" Blog Group... the blogs will not be updated on July 26, 27, 28, 29, and 30, 2026... We apologize for this, but we hope you understand that we deserve a break... We will return on July 31, God willing... Many thanks to all our readers and followers (whose numbers are constantly growing)... Until then... The Editor... "Equitable Health" Blog Group, owned by Víctor Norberto Cerasale Morteo, in Salta, Argentina... https://wwweldispreciau.blogspot.com/ https://eldispensador.blogspot.com/ https://saludequitativa.blogspot.com/ https://herenciageneticayenfermedad.blogspot.com/ https://elbiruniblogspotcom.blogspot.com/ Pause hivernale pour le groupe de blogs « Equitable Health »… Les articles ne seront pas mis à jour les 26, 27, 28, 29 et 30 juillet 2026… Nous vous prions de nous excuser pour ce désagrément, mais nous espérons que vous comprendrez que nous méritons bien une pause… Nous serons de retour le 31 juillet, si Dieu le veut… Un grand merci à tous nos lecteurs et abonnés (dont le nombre ne cesse de croître)… À bientôt… La rédaction… Le groupe de blogs « Equitable Health », propriété de Víctor Norberto Cerasale Morteo, à Salta, en Argentine… https://wwweldispreciau.blogspot.com/ https://eldispensador.blogspot.com/ https://saludequitativa.blogspot.com/ https://herenciageneticayenfermedad.blogspot.com/ https://elbiruniblogspotcom.blogspot.com/ Winterpause für die Bloggruppe „Gerechte Gesundheit“ … Die Blogs werden am 26., 27., 28., 29. und 30. Juli 2026 nicht aktualisiert. Wir bitten um Entschuldigung und hoffen auf Ihr Verständnis, dass wir uns eine Auszeit verdient haben. Wir sind am 31. Juli wieder für Sie da, so Gott will. Vielen Dank an alle unsere Leser und Follower (deren Zahl stetig wächst). Bis dahin … Die Redaktion der Bloggruppe „Gerechte Gesundheit“, Inhaber: Víctor Norberto Cerasale Morteo, Salta, Argentinien. https://wwweldispreciau.blogspot.com/ https://eldispensador.blogspot.com/ https://saludequitativa.blogspot.com/ https://herenciageneticayenfermedad.blogspot.com/ https://elbiruniblogspotcom.blogspot.com/ Зимний перерыв для блог-группы "Equitable Health"... блоги не будут обновляться 26, 27, 28, 29 и 30 июля 2026 года... Приносим свои извинения, но надеемся на ваше понимание, что мы заслужили перерыв... Мы вернемся 31 июля, если Бог даст... Большое спасибо всем нашим читателям и подписчикам (число которых постоянно растет)... До тех пор... Редактор... Блог-группа "Equitable Health", принадлежащая Виктору Норберто Серасале Мортео, Сальта, Аргентина... https://wwweldispreciau.blogspot.com/ https://eldispensador.blogspot.com/ https://saludequitativa.blogspot.com/ https://herenciageneticayenfermedad.blogspot.com/ https://elbiruniblogspotcom.blogspot.com/ "इक्विटेबल हेल्थ" ब्लॉग ग्रुप के लिए विंटर ब्रेक... ब्लॉग 26, 27, 28, 29, और 30 जुलाई, 2026 को अपडेट नहीं किए जाएंगे... हम इसके लिए माफ़ी चाहते हैं, लेकिन हमें उम्मीद है कि आप समझेंगे कि हम एक ब्रेक के हकदार हैं... हम 31 जुलाई को वापस आएंगे, भगवान चाहेंगे... हमारे सभी रीडर्स और फॉलोअर्स (जिनकी संख्या लगातार बढ़ रही है) का बहुत-बहुत धन्यवाद... तब तक... एडिटर... "इक्विटेबल हेल्थ" ब्लॉग ग्रुप, जिसके मालिक विक्टर नॉरबर्टो सेरासले मोर्टेओ हैं, साल्टा, अर्जेंटीना में है... https://wwweldispreciau.blogspot.com/ https://eldispensador.blogspot.com/ https://saludequitativa.blogspot.com/ https://herenciageneticayenfermedad.blogspot.com/ https://elbiruniblogspotcom.blogspot.com/ Recesso de Inverno para o Grupo de Blogs "Saúde Equitativa"... os blogs não serão actualizados nos dias 26, 27, 28, 29 e 30 de Julho de 2026... Pedimos desculpa por isso, mas esperamos que compreendam que merecemos uma pausa... Regressaremos no dia 31 de Julho, se Deus quiser... Muito obrigado a todos os nossos leitores e seguidores (cujo número está em constante crescimento)... Até lá... A Equipa Editorial... Grupo de Blogs "Saúde Equitativa", propriedade de Víctor Norberto Cerasale Morteo, em Salta, Argentina... https://wwweldispreciau.blogspot.com/ https://eldispensador.blogspot.com/ https://saludequitativa.blogspot.com/ https://herenciageneticayenfermedad.blogspot.com/ https://elbiruniblogspotcom.blogspot.com/ Pausa invernale per il gruppo di blog "Equitable Health"... i blog non verranno aggiornati il 26, 27, 28, 29 e 30 luglio 2026... Ci scusiamo per questo, ma speriamo che comprendiate che ci meritiamo una pausa... Torneremo il 31 luglio, a Dio piacendo... Un sentito ringraziamento a tutti i nostri lettori e follower (il cui numero è in costante crescita)... A presto... Il Direttore... Gruppo di blog "Equitable Health", di proprietà di Víctor Norberto Cerasale Morteo, a Salta, Argentina... https://wwweldispreciau.blogspot.com/ https://eldispensador.blogspot.com/ https://saludequitativa.blogspot.com/ https://herenciageneticayenfermedad.blogspot.com/ https://elbiruniblogspotcom.blogspot.com/ "ஈக்விடபிள் ஹெல்த்" வலைப்பதிவுக் குழுவிற்கு குளிர்கால இடைவேளை... ஜூலை 26, 27, 28, 29, மற்றும் 30, 2026 ஆகிய தேதிகளில் வலைப்பதிவுகள் புதுப்பிக்கப்படாது... இதற்காக வருந்துகிறோம், ஆனால் எங்களுக்கு ஒரு இடைவேளை தேவை என்பதை நீங்கள் புரிந்துகொள்வீர்கள் என்று நம்புகிறோம்... எல்லாம் வல்ல இறைவனின் அருளால், ஜூலை 31 அன்று நாங்கள் திரும்புவோம்... எங்கள் வாசகர்கள் மற்றும் பின்தொடர்பவர்கள் அனைவருக்கும் மிக்க நன்றி (அவர்களின் எண்ணிக்கை தொடர்ந்து அதிகரித்து வருகிறது)... அதுவரை... ஆசிரியர்... "ஈக்விடபிள் ஹெல்த்" வலைப்பதிவுக் குழு, விக்டர் நோர்பெர்டோ செராசேல் மோர்டியோவுக்குச் சொந்தமானது, சால்டா, அர்ஜென்டினா... https://wwweldispreciau.blogspot.com/ https://eldispensador.blogspot.com/ https://saludequitativa.blogspot.com/ https://herenciageneticayenfermedad.blogspot.com/ https://elbiruniblogspotcom.blogspot.com/ “公平健康”博客组冬季休刊……博客将于2026年7月26日、27日、28日、29日和30日暂停更新……对此我们深表歉意，但希望您能理解我们需要休息……我们将于7月31日恢复更新，如果一切顺利……非常感谢所有读者和关注者（人数还在不断增长）……此致……编辑……“公平健康”博客组，由阿根廷萨尔塔省的维克托·诺贝托·塞拉萨莱·莫特奥所有…… https://wwweldispreciau.blogspot.com/ https://eldispensador.blogspot.com/ https://saludequitativa.blogspot.com/ https://herenciageneticayenfermedad.blogspot.com/ https://elbiruniblogspotcom.blogspot.com/

Navigating Myelofibrosis-Associated Anemia Together: Empowering Collaboration and Communication Authors: Francesco Passamonti, MD

https://www.medscape.org/viewarticle/navigating-myelofibrosis-associated-anemia-together-2026a10007ks?page=1&src=mkmcmr_driv_stan_mscpedu_260720-OUS-HONC-navigating-myelofibrosis-associated-anemia-together-2026a10007ks-cta&uac=148436CN

Current and Future Oral SERD Strategies in the Management of ER-Positive/HER2-Negative MBC: Analyzing the Clinical Data Authors: Komal Jhaveri, MD, FACP, FASCO; Shaheenah Dawood, MD, MPH

https://www.medscape.org/viewarticle/current-and-future-oral-serd-strategies-management-er-2026a100022b?page=1&src=mkmcmr_driv_stan_mscpedu_260720-OUS-HONC-current-and-future-oral-serd-strategies-management-er-2026a100022b-cta&uac=148436CN

Future‑Ready Hematologists: Practical and Ethical Use of Artificial Intelligence (AI) in Hematology and Oncology Authors: Jakob N. Kather, MD, MSc; Chan Cheah, MBBS, DMSc; Matthew Lunning, DO, FACP

https://www.medscape.org/viewarticle/1003401?mkmcmr_driv_cust_mscpedu_260720-Global-HONC-1003401-cta&uac=148436CN

New therapy could offer alternative to hormone treatment for menopause symptoms A synthetic flavone restored vaginal tissue in a preclinical model, offering a potential nonsteroidal treatment for genitourinary syndrome of menopause. Written byBree Foster, PhD

https://www.drugdiscoverynews.com/new-therapy-could-offer-alternative-to-hormone-treatment-for-menopause-symptoms-17330 For millions of women, the symptoms of genitourinary syndrome of menopause (GSM) are an accepted but deeply disruptive part of aging. Vaginal dryness, irritation, pain during sex, recurrent vaginal and urinary tract infections, and urinary symptoms can affect daily life, relationships, and wellbeing. Yet, the condition remains widely underdiagnosed and undertreated.

Decision-Making for Managing Myelofibrosis-Related Cytopenias: What Is Best Practice? Authors: Paola Guglielmelli, MD, PhD

https://www.medscape.org/viewarticle/decision-making-managing-myelofibrosis-related-cytopenias-2026a1000ar2?page=1&src=mkmcmr_driv_stan_mscpedu_260720-OUS-HONC-decision-making-managing-myelofibrosis-related-cytopenias-2026a1000ar2-cta&uac=148436CN

Scientists discover a protein that protects the brain from Alzheimer’s damage A natural brain protein may help block the toxic tau damage that drives Alzheimer’s disease and other dementias.

https://www.sciencedaily.com/releases/2026/07/260718010140.htm A protein called SORLA may act as a powerful defense against the toxic tau tangles involved in Alzheimer’s disease. Mice with extra SORLA had less tau accumulation, less brain atrophy, and healthier connections between neurons, while mice without it experienced more severe damage. The findings also revealed a possible drug target that could help control harmful activity in supporting brain cells.

Class Action Settlement Scam Alert By Ivanhoe Broadcast News on July 16, 2026

Orlando, Fla. (Ivanhoe Newswire) — Millions of Americans receive class action settlement notices every year but many throw them away. The federal trade commission says just four percent of eligible consumers actually file claims. One reason? Fear of getting scammed and scammers know it. https://www.ivanhoe.com/smart-living/class-action-settlement-scam-alert/

The Dirt On Eating Clean By Ivanhoe Broadcast News on July 24, 2026

Orlando, Fla. (Ivanhoe Newswire) — We all want to eat healthy. But wanting and doing are two different things. A new Pew Research survey found about half of Americans say how healthy a food is, plays a major role in what they choose to eat. But Pew also found 84 percent of Americans believe healthy food costs more than less healthy options. While eating clean is a good idea, there can be some downsides. https://www.ivanhoe.com/?p=37357&preview=1&_ppp=044e91914b

Your Pick-Me-Up Problem: Stimulant Stacking By Ivanhoe Broadcast News on July 23, 2026

Orlando, Fla. (Ivanhoe Newswire) — About 90 percent of adults consume caffeine every single day, but most aren’t tracking how much they’re really getting. From drinks to supplements to workout boosters, experts say caffeine can add up fast and too much may do more than just make you jittery. https://www.ivanhoe.com/?p=37354&preview=1&_ppp=f33bf9e7d3

Live & Learn! The Skillcation Destination By Ivanhoe Broadcast News on July 22, 2026

Orlando, Fla. (Ivanhoe Newswire) — July is peak vacation season, and Americans are ready to go. A survey found 93 percent of Americans plan to travel this year. But for some, this year’s getaway isn’t just about relaxing, it’s about coming home with more than just souvenirs. https://www.ivanhoe.com/?p=37351&preview=1&_ppp=793411c0a9

You’re Fired! Now What? By Ivanhoe Broadcast News on July 21, 2026

Orlando, Fla. (Ivanhoe Newswire) — Layoffs continue to make headlines and for many workers, the biggest fear isn’t the economy itself, it’s whether they could be next. The latest U.S. Labor Department data shows about one-point-seven million Americans were laid off or discharged in April, while employers across technology, transportation, healthcare, finance, and retail continue to restructure their workforces. At the same time, hiring has slowed, making job searches more competitive than they were just a few years ago. And while some of the biggest companies in the country are cutting jobs, experts say losing a position doesn’t have to derail a career. So, what should you do if that shocking moment happens to you? https://www.ivanhoe.com/?p=37348&preview=1&_ppp=d8b9022f69

The Dangerous Dog Days Of Summer By Ivanhoe Broadcast News on July 20, 2026

Orlando, Fla. (Ivanhoe Newswire) — Temperatures are heating up and the dog days of summer can be deadlier than many pet owners realize. One large veterinary study found about one in seven dogs treated for heatstroke did not survive. And vets warn a dog’s body temperature above 106 degrees can cause permanent brain and organ damage. Here’s another surprise, the biggest trigger isn’t hot cars, it’s exercising in the heat. https://www.ivanhoe.com/smart-living/the-dangerous-dog-days-of-summer/

Heat–health action plans: guidance, second edition

https://iris.who.int/items/41fd7f17-5bf6-4395-b5db-bf142b862807 Extreme heat is an urgent and growing public health threat, driven by climate change and exacerbated by urbanization and population ageing. It increases morbidity and mortality, strains health and social care systems, and disproportionately affects populations at increased risk. Heat–health action plans (HHAPs) are a core public health response, enabling countries to anticipate and prepare for extreme heat, protect populations at increased risk, strengthen health system resilience, and reduce avoidable illness and deaths. This second, updated edition of WHO guidance on HHAPs supports countries in developing, strengthening and implementing such plans at national, regional and local levels. It offers an implementation-oriented framework, structured around eight core elements: governance; heat–health warning system; populations at increased risk; communication; health system resilience; reducing heat exposure; heat–health surveillance; and monitoring, evaluation and learning. The guidance also includes user action briefs for key sectors and a public health message bank to support effective risk communication with the public. It translates accumulated evidence and implementation experience into practical actions, tools and decision points for coordinated heat–health risk prevention and response. While tailored to the WHO European Region, it is adaptable to other contexts.

Mogamulizumab in Danish Patients With CTCL

Investigating Results From the MAVORIC Trial in Patients With CTCL

Increased Dosing Interval of Mogamulizumab in Patients With CTCL by CheckRare Staff| Published on: Jul 20, 2026

Increased Dosing Interval of Mogamulizumab in Patients With CTCL by CheckRare Staff| Published on: Jul 20, 2026 Christiane Querfeld, MD, PhD, dermatologist and and Director, Multidisciplinary Cutaneous Lymphoma Program, Professor at the City of Hope National Medical Center and the Beckman Research Institute, discusses the results of a new drug trial that increased the dosing interval of mogamulizumab in patients with CTCL. https://checkrare.com/increased-dosing-interval-of-mogamulizumab-in-patients-with-ctcl/

Catching the Clues, Changing the Course of Lysosomal Storage Disorders Professor Yoshikatsu Eto, Dr. Nicole Muschol, Professor Patrício Aguiar, Dr. Robert Hopkin

Catching the Clues, Changing the Course of Lysosomal Storage Disorders Illuminating the Complex Pathways of Rare Disease with Fabry Disease and Alpha-Mannosidosis in Focus Coverage of the 15th International Congress of Inborn Errors of Metabolism (ICIEM 2025) https://checkrare.com/catching-the-clues-changing-the-course-of-lysosomal-storage-disorders/

Rare Woman

https://editions.rarerevolutionmagazine.com/html5/reader/production/default.aspx?pubname=&edid=e0508b93-1cde-4785-b9ae-c36724bde55a&pnum=4 When Alena Yartseva (Kuratova) founded the DEBRA Russia in 2011, she set out to support Russian families living with epidermolysis bullosa (EB) and ichthyosis. Fifteen years on, with one of the world’s largest registries in genetic skin disease, a network of specialist centres across the country and federal funding for every EB patient now secured, her foundation has reached a conclusion drawn from its own data: the emotional condition of the mother is tracking her child’s clinical picture, and the centre of rare disease care needs to move with it.

Beyond the diagnosis—rights, access and everyday realities 15 July 2026

https://rarerevolutionmagazine.com/beyond-the-diagnosis-rights-access-and-everyday-realities/ Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare, autoimmune disease affecting the peripheral nervous system. Individuals living with CIDP often face systemic barriers preventing them from accessing knowledgeable expert care, basic rights and meaningful inclusion. Drawing on the collective experience of European advocates Gabi Faust, Jean-Philippe Plançon, Marian Ciopec and Nancy Di Salvo we discuss the geographical lottery of treatment access, workplace hurdles and global policy gaps preventing autonomy Written by Nicola Miller, RARE Revolution Community insights from Gabi Faust, chair, GBS CIDP Self-Help Organisation Jean-Philippe Plançon, president, EPODIN (European Patients Organization for Dysimmune and Inflammatory Neuropathies) Marian Ciopec, executive manager, EPODIN Nancy Di Salvo, international affairs director, GBS-CIDP Foundation International

Digital spaces: improving HIV prevention through social media among female sex workers in Cameroon Hassanatu Blake* [1,2] , Mercy Njah [3] , Mary Mah Babey [3] , Eveline Mboh Khan [3] , Anna Junkins [4] , Jodie Dionne [5] , Ann Montgomery [1] , Teneasha Washington [1] , Nataliya Ivankova [6] , Tamika Smith [1] , Pauline Jolly [4] + +...

https://www.academia.edu/3071-0324/2/2/10.20935/AcadPHealth8268 Introduction: Approximately 24.3% of female sex workers (FSWs) in Cameroon are living with human immunodeficiency virus (HIV). Social media platforms present new opportunities to improve HIV prevention efforts. This study examines the acceptance of Secret Facebook Groups (SFG) for HIV prevention education among FSWs in Western Cameroon and identifies barriers, facilitators, and recommendations for future interventions. Materials and methods: We conducted a qualitative study using semi-structured phone interviews with 20 FSWs aged ≥18 years during June 2022. We used purposeful convenience sampling to recruit participants from a 2021 parent study. Interview questions addressed social media platforms used for learning, challenges, and benefits of SFG for HIV prevention education, and recommendations for future interventions. We conducted thematic analysis using NVivo software with independent dual coding. Results: Five major themes emerged: (1) Facebook and WhatsApp were the most-used platforms; (2) FSWs acquired HIV prevention knowledge, including strategies and prevention tools; (3) challenges of using SFG to learn about HIV prevention included poor connectivity and infrastructure, limited data, educational level limitations, and financial support; (4) benefits included HIV prevention information, peer learning, privacy, and support; and (5) recommendations included WhatsApp as an alternative platform, improved communication, and technical support. Notably, participants consistently requested financial support, suggesting sustainability challenges for social media-based interventions in resource-limited settings. Conclusions: FSWs in this sample accepted SFG-based HIV prevention education because the intervention used a familiar platform, accommodated varying literacy levels, and provided privacy. However, better connectivity, higher education levels, and financing are needed to improve the intervention. Findings describe a digitally connected subgroup and cannot be generalized to other marginalized FSWs in Cameroon without reliable technology access. Future research should explore participatory approaches, evaluate effectiveness, and examine sustainability without external financial support. https://www.academia.edu/journals/academia-global-and-public-health/articles?source=journal-top-nav Receso Invernal del grupo de blog´s de "salud equitativa"... los días 26, 27, 28, 29, y 30 de julio de 2026, los blog´s no se actualizarán... pedimos disculpas por ello, pero esperamos sepan entender que merecemos un descanso... regresaremos el 31 de julio si Dios lo permite... muchas gracias a todos los lectores y seguidores (que cada vez son más)... hasta entonces... El editor... Grupo de blog´s de “salud equitativa”, cuyo titular es Víctor Norberto Cerasale Morteo, en Salta, Argentina… https://wwweldispreciau.blogspot.com/ https://eldispensador.blogspot.com/ https://saludequitativa.blogspot.com/ https://herenciageneticayenfermedad.blogspot.com/ https://elbiruniblogspotcom.blogspot.com/ Winter Break for the "Equitable Health" Blog Group... the blogs will not be updated on July 26, 27, 28, 29, and 30, 2026... We apologize for this, but we hope you understand that we deserve a break... We will return on July 31, God willing... Many thanks to all our readers and followers (whose numbers are constantly growing)... Until then... The Editor... "Equitable Health" Blog Group, owned by Víctor Norberto Cerasale Morteo, in Salta, Argentina... https://wwweldispreciau.blogspot.com/ https://eldispensador.blogspot.com/ https://saludequitativa.blogspot.com/ https://herenciageneticayenfermedad.blogspot.com/ https://elbiruniblogspotcom.blogspot.com/ Pause hivernale pour le groupe de blogs « Equitable Health »… Les articles ne seront pas mis à jour les 26, 27, 28, 29 et 30 juillet 2026… Nous vous prions de nous excuser pour ce désagrément, mais nous espérons que vous comprendrez que nous méritons bien une pause… Nous serons de retour le 31 juillet, si Dieu le veut… Un grand merci à tous nos lecteurs et abonnés (dont le nombre ne cesse de croître)… À bientôt… La rédaction… Le groupe de blogs « Equitable Health », propriété de Víctor Norberto Cerasale Morteo, à Salta, en Argentine… https://wwweldispreciau.blogspot.com/ https://eldispensador.blogspot.com/ https://saludequitativa.blogspot.com/ https://herenciageneticayenfermedad.blogspot.com/ https://elbiruniblogspotcom.blogspot.com/ Winterpause für die Bloggruppe „Gerechte Gesundheit“ … Die Blogs werden am 26., 27., 28., 29. und 30. Juli 2026 nicht aktualisiert. Wir bitten um Entschuldigung und hoffen auf Ihr Verständnis, dass wir uns eine Auszeit verdient haben. Wir sind am 31. Juli wieder für Sie da, so Gott will. Vielen Dank an alle unsere Leser und Follower (deren Zahl stetig wächst). Bis dahin … Die Redaktion der Bloggruppe „Gerechte Gesundheit“, Inhaber: Víctor Norberto Cerasale Morteo, Salta, Argentinien. https://wwweldispreciau.blogspot.com/ https://eldispensador.blogspot.com/ https://saludequitativa.blogspot.com/ https://herenciageneticayenfermedad.blogspot.com/ https://elbiruniblogspotcom.blogspot.com/ Зимний перерыв для блог-группы "Equitable Health"... блоги не будут обновляться 26, 27, 28, 29 и 30 июля 2026 года... Приносим свои извинения, но надеемся на ваше понимание, что мы заслужили перерыв... Мы вернемся 31 июля, если Бог даст... Большое спасибо всем нашим читателям и подписчикам (число которых постоянно растет)... До тех пор... Редактор... Блог-группа "Equitable Health", принадлежащая Виктору Норберто Серасале Мортео, Сальта, Аргентина... https://wwweldispreciau.blogspot.com/ https://eldispensador.blogspot.com/ https://saludequitativa.blogspot.com/ https://herenciageneticayenfermedad.blogspot.com/ https://elbiruniblogspotcom.blogspot.com/ "इक्विटेबल हेल्थ" ब्लॉग ग्रुप के लिए विंटर ब्रेक... ब्लॉग 26, 27, 28, 29, और 30 जुलाई, 2026 को अपडेट नहीं किए जाएंगे... हम इसके लिए माफ़ी चाहते हैं, लेकिन हमें उम्मीद है कि आप समझेंगे कि हम एक ब्रेक के हकदार हैं... हम 31 जुलाई को वापस आएंगे, भगवान चाहेंगे... हमारे सभी रीडर्स और फॉलोअर्स (जिनकी संख्या लगातार बढ़ रही है) का बहुत-बहुत धन्यवाद... तब तक... एडिटर... "इक्विटेबल हेल्थ" ब्लॉग ग्रुप, जिसके मालिक विक्टर नॉरबर्टो सेरासले मोर्टेओ हैं, साल्टा, अर्जेंटीना में है... https://wwweldispreciau.blogspot.com/ https://eldispensador.blogspot.com/ https://saludequitativa.blogspot.com/ https://herenciageneticayenfermedad.blogspot.com/ https://elbiruniblogspotcom.blogspot.com/ Recesso de Inverno para o Grupo de Blogs "Saúde Equitativa"... os blogs não serão actualizados nos dias 26, 27, 28, 29 e 30 de Julho de 2026... Pedimos desculpa por isso, mas esperamos que compreendam que merecemos uma pausa... Regressaremos no dia 31 de Julho, se Deus quiser... Muito obrigado a todos os nossos leitores e seguidores (cujo número está em constante crescimento)... Até lá... A Equipa Editorial... Grupo de Blogs "Saúde Equitativa", propriedade de Víctor Norberto Cerasale Morteo, em Salta, Argentina... https://wwweldispreciau.blogspot.com/ https://eldispensador.blogspot.com/ https://saludequitativa.blogspot.com/ https://herenciageneticayenfermedad.blogspot.com/ https://elbiruniblogspotcom.blogspot.com/ Pausa invernale per il gruppo di blog "Equitable Health"... i blog non verranno aggiornati il 26, 27, 28, 29 e 30 luglio 2026... Ci scusiamo per questo, ma speriamo che comprendiate che ci meritiamo una pausa... Torneremo il 31 luglio, a Dio piacendo... Un sentito ringraziamento a tutti i nostri lettori e follower (il cui numero è in costante crescita)... A presto... Il Direttore... Gruppo di blog "Equitable Health", di proprietà di Víctor Norberto Cerasale Morteo, a Salta, Argentina... https://wwweldispreciau.blogspot.com/ https://eldispensador.blogspot.com/ https://saludequitativa.blogspot.com/ https://herenciageneticayenfermedad.blogspot.com/ https://elbiruniblogspotcom.blogspot.com/ "ஈக்விடபிள் ஹெல்த்" வலைப்பதிவுக் குழுவிற்கு குளிர்கால இடைவேளை... ஜூலை 26, 27, 28, 29, மற்றும் 30, 2026 ஆகிய தேதிகளில் வலைப்பதிவுகள் புதுப்பிக்கப்படாது... இதற்காக வருந்துகிறோம், ஆனால் எங்களுக்கு ஒரு இடைவேளை தேவை என்பதை நீங்கள் புரிந்துகொள்வீர்கள் என்று நம்புகிறோம்... எல்லாம் வல்ல இறைவனின் அருளால், ஜூலை 31 அன்று நாங்கள் திரும்புவோம்... எங்கள் வாசகர்கள் மற்றும் பின்தொடர்பவர்கள் அனைவருக்கும் மிக்க நன்றி (அவர்களின் எண்ணிக்கை தொடர்ந்து அதிகரித்து வருகிறது)... அதுவரை... ஆசிரியர்... "ஈக்விடபிள் ஹெல்த்" வலைப்பதிவுக் குழு, விக்டர் நோர்பெர்டோ செராசேல் மோர்டியோவுக்குச் சொந்தமானது, சால்டா, அர்ஜென்டினா... https://wwweldispreciau.blogspot.com/ https://eldispensador.blogspot.com/ https://saludequitativa.blogspot.com/ https://herenciageneticayenfermedad.blogspot.com/ https://elbiruniblogspotcom.blogspot.com/ “公平健康”博客组冬季休刊……博客将于2026年7月26日、27日、28日、29日和30日暂停更新……对此我们深表歉意，但希望您能理解我们需要休息……我们将于7月31日恢复更新，如果一切顺利……非常感谢所有读者和关注者（人数还在不断增长）……此致……编辑……“公平健康”博客组，由阿根廷萨尔塔省的维克托·诺贝托·塞拉萨莱·莫特奥所有…… https://wwweldispreciau.blogspot.com/ https://eldispensador.blogspot.com/ https://saludequitativa.blogspot.com/ https://herenciageneticayenfermedad.blogspot.com/ https://elbiruniblogspotcom.blogspot.com/

Study reveals mechanism underlying HBV-induced liver inflammation

https://www.news-medical.net/news/20260717/Study-reveals-mechanism-underlying-HBV-induced-liver-inflammation.aspx Chronic hepatitis B virus (HBV) infection remains a major cause of global liver morbidity, leading to progressive necroinflammation that often culminates in cirrhosis and hepatocellular carcinoma. Despite the clinical significance of this chronic inflammatory state, the precise molecular mechanisms that initiate and sustain HBV-induced hepatic damage remain poorly understood.

Long-term study shows how neighborhood conditions shape women's heart health Download PDF Copy

https://www.news-medical.net/news/20260717/Long-term-study-shows-how-neighborhood-conditions-shape-womens-heart-health.aspx Women who live in disadvantaged neighborhoods face worse heart health and experience faster decline as they approach menopause, according to a long-term study led by the Harvard Pilgrim Health Care Institute. Researchers followed 1,200 women in eastern Massachusetts for more than 20 years, from pregnancy into midlife. The study, published in Circulation: Population Health and Outcomes, measured heart health at five time points using a score based on eight health and lifestyle factors, including blood pressure, cholesterol, sleep, diet, and physical activity.

African Heritage Diet Benefits for Gut Health and Metabolic Health

https://www.news-medical.net/health/African-Heritage-Diet-Benefits-for-Gut-Health-and-Metabolic-Health.aspx A traditional, fiber-rich way of eating may help reduce inflammation, support metabolic resilience, and preserve African food heritage amid rapid dietary westernization. The African heritage diet reflects traditional dietary patterns followed across African and African diaspora populations for generations. It should be understood as a culturally diverse family of regional foodways rather than a single fixed diet; current scoping evidence identifies cereals and cereal products, pulses, seeds, nuts, and vegetables as the most consistently reported continental African food groups, with fruits, roots, tubers, plantains, and their products also frequently described.

Cured Meats, Nitrates, and Cancer Risk: Why Food Source and Processing Matter

https://www.news-medical.net/health/Cured-Meats-Nitrates-and-Cancer-Risk-Why-Food-Source-and-Processing-Matter.aspx Cured and processed meats can promote the formation of carcinogenic N-nitroso compounds through nitrite chemistry, heme iron, smoking, and high-temperature cooking. Evidence most strongly links regular processed meat intake with increased colorectal cancer risk, while plant-derived nitrate behaves differently within an antioxidant-rich food matrix.

What Is the Baltic Sea Diet? Foods, Benefits, and Health Effects

https://www.news-medical.net/health/What-Is-the-Baltic-Sea-Diet-Foods-Benefits-and-Health-Effects.aspx Rooted in Nordic food traditions, the Baltic Sea diet may offer a practical, sustainable way to improve metabolic health while reducing reliance on processed foods.

COVID lockdown babies show language strengths at age four

https://www.news-medical.net/news/20260717/COVID-lockdown-babies-show-language-strengths-at-age-four.aspx Four-year-olds born during England's first lockdown performed well in many language and reasoning tests, but researchers found signs that executive function skills may need extra support as this generation progresses through school. A recent Archives of Disease in Childhood study assessed the development of four-year-old children born during the coronavirus disease 2019 (COVID-19) lockdowns.

Kitchen Sponges: Can They Look Clean but Harbor Pathogens? Michael van den Heuvel Medscape Europe logo July 14, 2026 J Food Prot. 2026;89(6):100794. doi:10.1016/j.jfp.2026.100794

https://www.medscape.com/viewarticle/kitchen-sponges-can-they-look-clean-harbor-pathogens-2026a1000nr7?ecd=WNL_trdalrt_pos1_ous_260717_etid8513457&uac=148436CN&impID=8513457 Kitchen sponges are among the most commonly used cleaning tools in homes, yet they may also be one of the underestimated sources of foodborne pathogens. Researchers at the German Federal Institute for Risk Assessment (BfR) found that Escherichia coli, Salmonella enteritidis, and Staphylococcus aureus can multiply rapidly in kitchen sponges, even when only small numbers of bacteria are initially present. Importantly, unpleasant odors, discoloration, and a slimy surface did not reliably indicate microbial contamination.

FDA Approves First Oral Therapy that Inhibits Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) to Lower Bad Cholesterol in Adults with High Cholesterol

https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-first-oral-therapy-inhibits-proprotein-convertase-subtilisinkexin-type-9-pcsk9-lower?utm_medium=email&utm_source=govdelivery

HER2-Mutated NSCLC: Are Your Clinical Decisions on Target? Authors: Nicolas Girard, MD, PhD

https://www.medscape.org/viewarticle/her2-mutated-nsclc-are-your-clinical-decisions-target-2026a10000gu?page=1&uac=148436CN&src=mkmcmr_driv_stan_mscpedu_260717-OUS-HONC-her2-mutated-nsclc-are-your-clinical-decisions-target-2026a10000gu-cta

Weekly Rundown: Biogen pushes anti-tau drug into Phase 3 after endpoint miss Psychedelic acquisitions, clinical trial updates, and more led the news this week. Written byDDN editorial team

Weekly Rundown: Biogen pushes anti-tau drug into Phase 3 after endpoint miss Psychedelic acquisitions, clinical trial updates, and more led the news this week. Written byDDN editorial team https://www.drugdiscoverynews.com/weekly-rundown-biogen-pushes-anti-tau-drug-into-phase-3-after-endpoint-miss-17334?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz-_sK8zS5Oq0Bc32SLsxkXnMzIFGXNWdTPxZ4YPgbfSfwN4sZT4_8ZkKGLtf7LxG7QbmixhqC9_2vTqNzNylt43Zm6lxTQ&_hsmi=428888569&utm_content=428888569&utm_source=hs_email Biogen's tau-targeting investigational antisense oligonucleotide therapy diranersen failed its primary Phase 2 endpoint of demonstrating a dose-dependent reduction in brain tau, dropping the company's shares by around eight percent. However, the drug still showed enough promise to propel it into late-stage testing. Data from the CELIA trial presented at the Alzheimer's Association International Conference in London showed that all three doses outperformed placebo after 18 months, although the lowest 60mg dose produced the strongest results. That arm slowed decline on the Clinical Dementia Rating Sum of Boxes (CDR-SB) scale by 26 percent and delivered consistent reductions in brain tau, marking the first Phase 2 evidence that a drug can remove toxic tau tangles in people with Alzheimer's disease. Despite the failed primary endpoint and questions over the dose-response findings, the company plans to advance diranersen into Phase 3, with the cognitive signal and tau reductions offering a potential new approach alongside approved amyloid-targeting therapies. – Bree Foster

Rare Disease Focus: Hematologic Disorders +++ +++ +++

FEATURED ARTICLES CTCL Medical Treatment and Stem-Cell Transplantation in Patients With Cutaneous T-Cell Lymphoma https://checkrare.com/medical-treatment-and-stem-cell-transplantation-in-patients-with-cutaneous-t-cell-lymphoma/ Lauren Shea, MD, Assistant Professor of Hematology and Oncology, University of Alabama, Birmingham, discusses important aspects of medical treatment and stem-cell transplantation in patients with cutaneous T-cell lymphoma (CTCL). Prospective Cutaneous Lymphoma International Prognostic Index Study https://checkrare.com/prospective-cutaneous-lymphoma-international-prognostic-index-study/ Julia Scarisbrick, MD, MBhons, ChB, FRCP, Professor of Dermatology, Department of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom, one of the leaders of the PROCLIPI (Prospective Cutaneous Lymphoma International Prognostic Index) study, a registry of patients with cutaneous T-cell lymphoma (CTCL), discusses the study’s objectives, as well as challenges in the diagnosis of CTCL. Systemic Mastocytosis An Overview of Systemic Mastocytosis https://checkrare.com/an-overview-of-systemic-mastocytosis/ Dareen D. Siri, MD, FAAAAI, FACAAI, board-certified allergist and immunologist practicing at Midwest Allergy Sinus Asthma, discusses a unique, rare disorder called systemic mastocytosis. Beyond the Rash: Recognizing and Managing Systemic Mastocytosis in Clinical Practice https://checkrare.com/beyond-the-rash-recognizing-and-managing-systemic-mastocytosis-in-clinical-practice/ Patrick C. Foy, MD, a Clinical Hematologist practicing at Froedtert Hospital, Milwaukee, and Associate Professor, Medical College of Wisconsin, discusses the diagnostic challenges of systemic mastocytosis and optimizing patient care. Results of the Phase 2 PIONEER Study in Patients With Systemic Mastocytosis https://checkrare.com/results-of-the-phase-2-pioneer-study-in-patients-with-systemic-mastocytosis/ Cem Akin, MD, PhD, Professor, Allergy and Immunology at the University of Michigan, discusses systemic mastocytosis, and the results of the phase 2 PIONEER study, which tested the tyrosine-kinase inhibitor avapritinib (Ayvakit) against placebo in symptomatic patients. PLGD-1 Plasminogen Deficiency: Fibrin Accumulation and Its Effects on Patients https://checkrare.com/plasminogen-deficiency-fibrin-accumulation-and-its-effects-on-patients-2/ Plasminogen is a precursor protein that is converted into plasmin. Plasmin is crucial to break down fibrin, the main protein component of blood clots. When the body does not produce sufficient plasminogen or does not produce adequate active plasminogen, fibrin can accumulate in mucous membranous areas throughout the body. Type 1 Plasminogen Deficiency Overview https://checkrare.com/type-1-plasminogen-deficiency-overview/ Amy Shapiro, MD, a pediatric hematologist and the Medical Director and CEO of the Indiana Hemophilia and Thrombosis Center in Indianapolis, provides CheckRare an overview on type 1 plasminogen deficiency (PLGD-1). Diagnosis and Management of Plasminogen Deficiency https://checkrare.com/diagnosis-and-management-of-plasminogen-deficiency/ Amol Sura, MD, discusses the diagnosis and management of plasminogen deficiency, a rare condition that manifests in mucous membranes. Key Features of PLGD-1 https://checkrare.com/diagnosis-and-management-of-plasminogen-deficiency-2/ Angela Zhu, MD, Ophthalmologist and Clinical Assistant Professor, Pediatric & Adult Cornea/Cataract/External Diseases, at Bascom Palmer Eye Institute in Miami, describes some of the key features of plasminogen deficiency and why ophthalmologists are often the healthcare providers who begin the process toward diagnosis.

Highlights From the Annual Neuro-Oncology Conference: Redefining IDH-Mutant Glioma Management Authors: Evanthia Galanis, MD; Shawn Hervey-Jumper, MD; Katherine B. Peters, MD, PhD, FAAN; Matthias Preusser, MD

https://www.medscape.org/viewarticle/1003198?src=mkmcmr_driv_stan_mscpedu_260718-OUS-HONC-1003198-cta&uac=148436CN

Patient-reported behavioral health outcomes in a hospital-based violence intervention program Damaris Ortiz* [1,2] , Akrem Ahmed [3] , Samantha Padgett [2] , Natalia Chaudhry [1] , Lauren A. Magee [4] , Blakney Q. Brooks [2] , Sydney Doyle [2] , Clark J. Simons [1,2] , Malaz Boustani [5] , Ben Zarzaur [6] ++...

https://www.academia.edu/2997-9196/3/2/10.20935/MHealthWellB8356 Introduction: Hospital-based violence intervention programs (HVIPs) provide resources to violently injured patients in the United States but do not have robust program evaluation plans that incorporate behavioral health and socioemotional outcomes. This study aimed to evaluate a well-established HVIP with patient-reported outcome measures, including socioemotional and behavioral health outcomes. Materials and methods: This was a retrospective analysis of prospectively collected routine program data from HVIP participants enrolled from 1 June 2022 to 12 December 2024. Post-traumatic stress disorder (PTSD) and depression symptoms and measures of self-efficacy and satisfaction with social roles and activities were compared at baseline, 3 months, and 6 months using a mixed-effect model, permutation testing, and the Reliable Change Index. Results: Fifty-seven participants were enrolled in the HVIP during the study period; three were excluded. Twenty participants (37%) completed the assessments at all time points. Forty-nine (90.7%) participants screened positive for either PTSD or depression symptoms, and 26 (53%) engaged in therapy. There were no differences over time in PTSD (β = −4.28, SE = 2.55, p = 0.093), depression (β = −0.67, SE = 1.02, p = 0.512), or other measure scores (social roles (β = 1.04, SE = 1.25, p = 0.406)), (self-efficacy (β = 1.39, SE = 1.18, p = 0.240)). There was significant score variance within and between participants. Conclusions: HVIPs can screen for PTSD and depression symptoms and connect patients to needed therapy. This longitudinal assessment was limited by participant attrition. Further study is needed to determine within- and between-participant variability, which HVIP interventions should remain standard, and which interventions should be individualized. https://www.academia.edu/journals/academia-mental-health-and-well-being/articles?source=journal-top-nav

Why France Is Leading on Tick-Borne Diseases Interviewer: Caroline Guignot; Interviewee: Alice Raffetin, MD ++

https://www.medscape.com/viewarticle/why-france-leading-tick-borne-diseases-2026a1000obr?ecd=wnl_edit_tpal_etid8518360&uac=148436CN&impID=8518360 Alice Raffetin, MD, an infectious disease specialist at the Centre Hospitalier Intercommunal in Villeneuve-Saint-Georges, France, and coordinator of the Regional Reference Center for tick-borne diseases for Paris and the Northern Region, France, provides an overview of the situation in the country, which is particularly active in addressing these diseases. England to Screen Newborns for Spinal Muscular Atrophy Dr Sheena Meredith https://www.medscape.com/viewarticle/england-screen-newborns-spinal-muscular-atrophy-2026a1000od0?ecd=wnl_edit_tpal_etid8518360&uac=148436CN&impID=8518360 Newborn babies in England are to be tested for spinal muscular atrophy (SMA) straight after birth, under a national screening evaluation programme designed to catch the rare genetic condition before symptoms appear — when treatment has the best chance of changing a child’s future.

Controversies: Hormone Replacement Therapy in Patients With Osteoporosis Kaniksha Desai, MD; Ejigayehu Abate, MD

https://www.medscape.com/viewarticle/controversies-hormone-replacement-therapy-patients-2026a1000ngj?ecd=wnl_edit_tpal_etid8518360&uac=148436CN&impID=8518360

Chronic Lymphocytic Leukemia (CLL): Review of Combination Approaches Authors: Jonathon Cohen, MD, MS; Matthew S. Davids, MD, MMSc

https://www.medscape.org/viewarticle/chronic-lymphocytic-leukemia-cll-review-combination-2026a10004ku?page=1&uac=148436CN&src=mkmcmr_driv_stan_mscpedu_260718-OUS-HONC-chronic-lymphocytic-leukemia-cll-review-combination-2026a10004ku-cta

Is Normalizing Hemostasis an Achievable Goal in Hemophilia A? Authors: Cedric Hermans, MD, PhD, FRCP; Robert Klamroth, MD

https://www.medscape.org/viewarticle/normalizing-hemostasis-achievable-goal-hemophilia-2026a1000jxv?page=2&uac=148436CN&src=mkmcmr_driv_il_mscpedu_260718_&subtitle-lang-code=es Is Normalizing Hemostasis an Achievable Goal in Hemophilia A? Authors: Cedric Hermans, MD, PhD, FRCP; Robert Klamroth, MD https://www.medscape.org/viewarticle/normalizing-hemostasis-achievable-goal-hemophilia-2026a1000jxv?page=1&uac=148436CN&src=mkmcmr_driv_il_mscpedu_260718_12280132_#transcript-download-es

Navigating Cytopenias in Myelofibrosis: Tailoring Personalized Care for Optimal Outcomes Authors: Francesca Palandri, MD; Vikas Gupta, MD, FRCPath; Jennifer O'Sullivan, MD

https://www.medscape.org/viewarticle/navigating-cytopenias-myelofibrosis-tailoring-personalized-2026a10004km?page=1&src=mkmcmr_driv_stan_mscpedu_260718-OUS-HONC-navigating-cytopenias-myelofibrosis-tailoring-personalized-2026a10004km-cta&uac=148436CN

Beyond the Update in Advanced/Recurrent Endometrial Cancer: How Evidence Is Shaping New Guidelines Authors: Nicole Concin, MD, PhD; Els Van Nieuwenhuysen, MD, PhD; Xavier Matias-Guiu, MD, PhD

https://www.medscape.org/viewarticle/beyond-update-advanced-recurrent-endometrial-cancer-how-2026a10006up?page=1&src=mkmcmr_driv_stan_mscpedu_260719-OUS-HONC-beyond-update-advanced-recurrent-endometrial-cancer-how-2026a10006up-cta&uac=148436CN

The Alarming Rise of Early-Onset Lung and GI Cancers Coral Olazagasti, MD; Carolina Bernabe, MD

https://www.medscape.com/viewarticle/alarming-rise-early-onset-lung-and-gi-cancers-2026a1000lvr?src=

Monoclonal Gammopathy of Renal Significance Relapse-Free Survival Better With Maintenance Therapy Edited by Katie Lennon

https://www.medscape.com/viewarticle/monoclonal-gammopathy-renal-significance-relapse-free-2026a1000o0c?src= Maintenance therapy and treatment duration longer than 6 months are associated with improved relapse-free survival in patients with monoclonal gammopathy of renal significance (MGRS), according to a retrospective analysis of 50 patients. Among patients with a plasma cell clone, median relapse-free survival was not reached with maintenance therapy vs 2.9 years without maintenance.

Germline Profiling May Improve Risk Stratification in Therapy-Related Myeloid Neoplasms Edited by Gargi Mukherjee

https://www.medscape.com/viewarticle/germline-profiling-may-improve-risk-stratification-therapy-2026a1000oag?src= Researchers used germline variants to stratify therapy-related myeloid neoplasms (t-MNs) into molecularly and prognostically distinct subgroups beyond treatment-based classifications. They found that germline mutations in cancer predisposition genes identified a high-risk subgroup of t-MNs characterized by complex karyotypes and poor survival. Patients with myeloid-related germline variants or no germline mutations had more favorable outcomes.

Algorithm Rules Out Pulmonary Embolism in Patients With Cancer Ernie Mundell

https://www.medscape.com/viewarticle/algorithm-rules-out-pulmonary-embolism-patients-cancer-2026a1000o8g?src= The first randomized trial of its kind concludes that an algorithm widely used to rule out pulmonary embolism (PE) can safely be extended to patients with cancer.

Chordoma Guidance Moves Into Age of Shared Decision-Making, Staging With Molecular Biomarkers Richard Mark Kirkner

https://www.medscape.com/viewarticle/chordoma-guidance-moves-age-shared-decision-making-staging-2026a1000oa4 The Global Chordoma Consensus Group is calling for shared decision-making, more use of molecular biomarkers for staging, and refined protocols for site-specific surgery in the care of patients with primary, localized chordoma. Their new recommendations were written by a panel of 150 experts from a variety of specialties, including pathology, radiology, and surgery, who reviewed 305 articles from 2010 to 2025. The updated guidance replaces a 2015 consensus statement in which 40 chordoma experts participated. The new guidance, which was published in JAMA Oncology, is more detailed than the 2015 statement, Joseph Schwab, MD, a member of the consensus group, told Medscape Medical News.

Remedi4all Hackathon

https://remedi4all.org/resources/remedi4all-repurposing-academy/remedi4all-hackathon/ The REMEDi4ALL Repurposing Hackathon is designed to help early career researchers learn by doing. Join a small team of international trainees keen to learn about the repurposing pathway on a week-long residential course where you aim to plan the development of a repurposing candidate for a specific patient community.

Starting a patient organisation ++

https://pierrerobineurope.com/ The EURORDIS member organisation Pierre Robin Europe have published a new article, providing easy-to-follow, practical advice on setting up a rare disease patient organisation. From launching a group on Facebook to building a website, this article offers all the information you need to create a successful rare disease patient organisation. https://pierrerobineurope.com/how-to-build-a-rare-disease-patient-organization/

Welcome To IRDiRC ++ Our vision: Enable all people living with a rare disease to receive an accurate diagnosis, care, and available therapy within one year of coming to medical attention

https://irdirc.org/ IRDiRC Call for Nominations IRDiRC is looking for rare disease experts to join the Interdisciplinary Scientific Committee (ISC). Applications close on 27 July 2026, and are open to experts with experience in policy, public affairs or education and capacity building. Applicants should also have a strong understanding of the rare disease landscape and be committed to collaboration and active participation. Learn more. https://irdirc.org/call-for-new-members/